As of late September 2026, U.S. measles cases have reached 3,659 confirmed infections—the highest annual total since 1991—driven primarily by sustained domestic transmission in multiple states, with 95% of cases outbreak-associated and 95% occurring in unvaccinated or unknown-status individuals. Official CDC data show 9% hospitalization rates and two verified measles-related deaths, amid ongoing outbreaks concentrated in areas with declining MMR vaccine coverage. This exceeds the full 2025 total of 2,289 cases and reflects eroded herd immunity thresholds, as two-dose MMR efficacy is approximately 97%. Traders should monitor weekly CDC surveillance updates through year-end and seasonal respiratory virus trends that could accelerate spread in the final quarter.